|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) attributable to noncontrolling interests | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization expense | |||||
| Amortization of debt issuance costs and discount | |||||
| Equity-based compensation expense | |||||
| (Gain) loss on sale of joint ventures | |||||
| Loss on extinguishment of debt | |||||
| (Gain) loss on change in fair value of committed equity facility | |||||
| (Gain) loss on change in fair value of warrants | |||||
| Deferred provision (benefit) for income taxes | |||||
| Impairment expense | |||||
| Income from equity method investments | |||||
| Non-cash lease expense | |||||
| Non-cash interest expense | |||||
| Purchase accounting fair value adjustment related to inventory | |||||
| Other | |||||
| Changes in assets and liabilities: | |||||
| (Increase) decrease in accounts receivable | |||||
| (Increase) decrease in contract assets | |||||
| (Increase) decrease in inventory | |||||
| (Increase) decrease in prepaid insurance | |||||
| (Increase) decrease in prepaid expenses and other assets | |||||
| Increase (decrease) in accounts payable and accrued expenses | |||||
| Increase (decrease) in deferred revenue | |||||
| Increase (decrease) in operating lease liabilities | |||||
| Increase (decrease) in other liabilities | |||||
| Increase (decrease) in notes payable to sellers | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Net proceeds from sale of joint ventures | |||||
| Purchases of property, plant and equipment | |||||
| Purchase of intangible assets | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds received from debt | |||||
| Repayments of debt | |||||
| Payment of debt issuance fees | |||||
| Repayment of finance leases | |||||
| Proceeds from (repayment of) third-party advances | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from issuance of convertible preferred stock | |||||
| Payment of equity issuance costs | |||||
| Payments of issuance costs related to convertible preferred stock | |||||
| Shares repurchased for settlement of employee tax withholdings on share-based awards | |||||
| Payment of contingent earnout | |||||
| Repurchase of convertible preferred stock | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of foreign currency rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Interest | |||||
| Income taxes | |||||
| Capital expenditures not yet paid | |||||
Loading...